María Teruel,
Carmen P Simeon,
Jasper Broen,
Madelon C Vonk,
Patricia Carreira, Maria Teresa Camps,
Rosa García-Portales,
Esmeralda Delgado-Frías,
Maria Gallego,
Gerard Espinosa, [......],
Thomas Krieg,
Alexander Kreuter,
Jörg Hw Distler,
Nicolas Hunzelmann,
Bobby P Koeleman,
Alexandre E Voskuyl,
Annemie J Schuerwegh,
Miguel Angel González-Gay,
Timothy Rdj Radstake,
Javier Martin
[show abstract]
[hide abstract]
ABSTRACT: INTRODUCTION: The aim of the present study was to investigate the possible role of CD40 and CD40 ligand (CD40LG) genes in the susceptibility and phenotype expression of systemic sclerosis (SSc). METHODS: In total, 2,670 SSc patients and 3,245 healthy individuals from four European populations (Spain, Germany, The Netherlands, and Italy) were included in the study. Five single-nucleotide polymorphisms (SNPs) of CD40 (rs1883832, rs4810485, rs1535045) and CD40LG (rs3092952, rs3092920) were genotyped by using a predesigned TaqMan allele-discrimination assay technology. Meta-analysis was assessed to determine whether an association exists between the genetic variants and SSc or its main clinical subtypes. RESULTS: No evidence of association between CD40 and CD40LG genes variants and susceptibility to SSc was observed. Similarly, no significant statistical differences were observed when SSc patients were stratified by the clinical subtypes, the serologic features, and pulmonary fibrosis. CONCLUSIONS: Our results do not suggest an important role of CD40 and CD40LG gene polymorphisms in the susceptibility to or clinical expression of SSc.
Arthritis research & therapy 06/2012; 14(3):R154. · 4.27 Impact Factor
